A tale from TGF-β superfamily for thymus ontogeny and function

Frontiers in Immunology

Volumn 6, Issue SEP, 2015, Pages

  Jurberg, Arnon Dias ^a,b   Vasconcelos Fontes, Larissa ^a   Cotta de Almeida, Vinícius ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

TGF , BMP, thymus, thymopoiesis, T cell development

Indexed keywords

BONE MORPHOGENETIC PROTEIN 4; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CCR9; CLAUDIN 3; COLLAGEN TYPE 1; COLLAGEN TYPE 3; CYTOKERATIN 5; FORKHEAD TRANSCRIPTION FACTOR; GROWTH DIFFERENTIATION FACTOR; INTERLEUKIN 17; KERATINOCYTE GROWTH FACTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NOGGIN; OSTEOGENIC PROTEIN 1; RAG2 PROTEIN; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; TRANSFORMING GROWTH FACTOR BETA; WNT4 PROTEIN; YELLOW FLUORESCENT PROTEIN;

AGGREGATIBACTER ACTINOMYCETEMCOMITANS; AGING; CD4 CD8 RATIO; DENDRITIC CELL; HUMAN; LYMPHOID PROGENITOR CELL; NEURAL CREST CELL; ONTOGENY; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE; THYMUS FUNCTION;

EID: 84946565915     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2015.00442     Document Type: Review

References (221)

1. Flajnik MF, Kasahara M. Origin and evolution of the adaptive immune system: genetic events and selective pressures. Nat Rev Genet (2010) 11:47-59. doi:10.1038/nrg2703.
2. Cowan JE, Jenkinson WE, Anderson G. Thymus medulla fosters generation of natural Treg cells, invariant γδ T cells, and invariant NKT cells: what we learn from intrathymic migration. Eur J Immunol (2015) 45:652-60. doi:10.1002/eji.201445108.
3. Agosti V, Corbacioglu S, Ehlers I, Waskow C, Sommer G, Berrozpe G, et al. Critical role for Kit-mediated Src kinase but not PI 3-kinase signaling in pro T and pro B cell development. J Exp Med (2004) 199:867-78. doi:10.1084/jem.20031983.
4. Fry TJ, Sinha M, Milliron M, Chu YW, Kapoor V, Gress RE, et al. Flt3 ligand enhances thymic-dependent and thymic-independent immune reconstitution. Blood (2004) 104:2794-800. doi:10.1182/blood-2003-11-3789.
5. Besseyrias V, Fiorini E, Strobl LJ, Zimber-strobl U, Dumortier A, Koch U, et al. Hierarchy of Notch-Delta interactions promoting T cell lineage commitment and maturation. J Exp Med (2007) 204:331-43. doi:10.1084/jem.20061442.
6. Magri M, Yatim A, Benne C, Balbo M, Henry A, Serraf A, et al. Notch ligands potentiate IL-7-driven proliferation and survival of human thymocyte precursors. Eur J Immunol (2009) 39:1231-40. doi:10.1002/eji.200838765.
7. Petrie HT, Zúñiga-Pflücker JC. Zoned out: functional mapping of stromal signaling microenvironments in the thymus. Annu Rev Immunol (2007) 25:649-79. doi:10.1146/annurev.immunol.23.021704.115715.
8. Urist MR. Bone: formation by autoinduction. Science (1965) 150:893-9. doi:10.1126/science.150.3698.893.
9. De Larco JE, Todaro GJ. Growth factors from murine sarcoma virus-transformed cells. Proc Natl Acad Sci U S A (1978) 75:4001-5. doi:10.1073/pnas.75.8.4001.
10. Roberts AB, Lamb LC, Newton DL, Sporn MB, De Larco JE, Todaro GJ. Transforming growth factors: isolation of polypeptides from virally and chemically transformed cells by acid/ethanol extraction. Proc Natl Acad Sci U S A (1980) 77:3494-8. doi:10.1073/pnas.77.6.3494.
11. Frolik CA, Dart LL, Meyers CA, Smith DM, Sporn MB. Purification and initial characterization of a type beta transforming growth factor from human placenta. Proc Natl Acad Sci U S A (1983) 80:3676-80. doi:10.1073/pnas.80.12.3676.
12. Wrana JL. Signaling by the TGFβ superfamily. Cold Spring Harb Perspect Biol (2013) 5:a011197. doi:10.1101/cshperspect.a011197.
13. Constam DB. Regulation of TGFβ and related signals by precursor processing. Semin Cell Dev Biol (2014) 32:85-97. doi:10.1016/j.semcdb.2014.01.008.
14. Degnin C, Jean F, Thomas G, Christian JL. Cleavages within the prodomain direct intracellular trafficking and degradation of mature bone morphogenetic protein-4. Mol Biol Cell (2004) 15:5012-20. doi:10.1091/mbc. E04-08-0673.
15. Nelsen SM, Christian JL. Site-specific cleavage of BMP4 by furin, PC6, and PC7. J Biol Chem (2009) 284:27157-66. doi:10.1074/jbc. M109.028506.
16. Li Z, Kawasumi M, Zhao B, Moisyadi S, Yang J. Transgenic over-expression of growth differentiation factor 11 propeptide in skeleton results in transformation of the seventh cervical vertebra into a thoracic vertebra. Mol Reprod Dev (2010) 77(11):990-7. doi:10.1002/mrd.21252.
17. Wrana JL, Attisano L, Wieser R, Ventura F, Massagué J. Mechanism of activation of the TGF-beta receptor. Nature (1994) 370:341-7. doi:10.1038/370341a0.
18. Kretzschmar M, Liu F, Hata A, Doody J, Massagué J. The TGF-β family mediator Smad1 is phosphorylated directly and activated functionally by the BMP receptor kinase. Genes Dev (1997) 11:984-95. doi:10.1101/gad.11.8.984.
19. Massagué J, Gomis RR. The logic of TGFβ signaling. FEBS Lett (2006) 580:2811-20. doi:10.1016/j.febslet.2006.04.033.
20. Mueller TD, Nickel J. Promiscuity and specificity in BMP receptor activation. FEBS Lett (2012) 586:1846-59. doi:10.1016/j.febslet.2012.02.043.
21. Ten Dijke P, Ichijo H, Franzén P, Schulz P, Saras J, Toyoshima H, et al. Activin receptor-like kinases: a novel subclass of cell-surface receptors with predicted serine/threonine kinase activity. Oncogene (1993) 8:2879-87.
22. Wu G, Chen YG, Ozdamar B, Gyuricza CA, Chong PA, Wrana JL, et al. Structural basis of Smad2 recognition by the Smad anchor for receptor activation. Science (2000) 287:92-7. doi:10.1126/science.287.5450.92.
23. Shi Y, Wang YF, Jayaraman L, Yang H, Massagué J, Pavletich NP. Crystal structure of a Smad MH1 domain bound to DNA: insights on DNA binding in TGF-beta signaling. Cell (1998) 94:585-94. doi:10.1016/S0092-8674(00)81600-1.
24. Zawel L, Dai JL, Buckhaults P, Zhou S, Kinzler KW, Vogelstein B, et al. Human Smad3 and Smad4 are sequence-specific transcription activators. Mol Cell (1998) 1:611-7. doi:10.1016/S1097-2765(00)80061-1.
25. Makkar P, Metpally RPR, Sangadala S, Reddy BVB. Modeling and analysis of MH1 domain of Smads and their interaction with promoter DNA sequence motif. J Mol Graph Model (2009) 27:803-12. doi:10.1016/j.jmgm.2008.12.003.
26. Xiao Z, Latek R, Lodish HF. An extended bipartite nuclear localization signal in Smad4 is required for its nuclear import and transcriptional activity. Oncogene (2003) 22:1057-69. doi:10.1038/sj.onc.1206212.
27. Chacko BM, Qin BY, Tiwari A, Shi G, Lam S, Hayward LJ, et al. Structural basis of heteromeric smad protein assembly in TGF-beta signaling. Mol Cell (2004) 15:813-23. doi:10.1016/j.molcel.2004.07.016.
28. Baburajendran N, Jauch R, Tan CYZ, Narasimhan K, Kolatkar PR. Structural basis for the cooperative DNA recognition by Smad4 MH1 dimers. Nucleic Acids Res (2011) 39:8213-22. doi:10.1093/nar/gkr500.
29. Chen X, Xu L. Specific nucleoporin requirement for Smad nuclear translocation. Mol Cell Biol (2010) 30:4022-34. doi:10.1128/MCB.00124-10.
30. Cautain B, Hill R, de Pedro N, Link W. Components and regulation of nuclear transport processes. FEBS J (2015) 282:445-62. doi:10.1111/febs.13163.
31. Morikawa M, Koinuma D, Miyazono K, Heldin C-H. Genome-wide mechanisms of Smad binding. Oncogene (2012) 32:1-7. doi:10.1038/onc.2012.191.
32. Ross S, Hill CS. How the Smads regulate transcription. Int J Biochem Cell Biol (2008) 40:383-408. doi:10.1016/j.biocel.2007.09.006.
33. Shi Y, Massagué J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell (2003) 113:685-700. doi:10.1016/S0092-8674(03)00432-X.
34. Imamura T, Takase M, Nishihara A, Oeda E, Hanai J, Kawabata M, et al. Smad6 inhibits signalling by the TGF-beta superfamily. Nature (1997) 389:622-6. doi:10.1038/39355.
35. Hanyu A, Ishidou Y, Ebisawa T, Shimanuki T, Imamura T, Miyazono K. The N domain of Smad7 is essential for specific inhibition of transforming growth factor-beta signaling. J Cell Biol (2001) 155:1017-27. doi:10.1083/jcb.200106023.
36. Kavsak P, Rasmussen RK, Causing CG, Bonni S, Zhu H, Thomsen GH, et al. Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGFβ receptor for degradation. Mol Cell (2000) 6:1365-75. doi:10.1016/S1097-2765(00)00134-9.
37. Feng X-H, Derynck R. Specificity and versatility in Tgf-beta signaling through Smads. Annu Rev Cell Dev Biol (2005) 21:659-93. doi:10.1146/annurev.cellbio.21.022404.142018.
38. Wu MY, Hill CS. Tgf-beta superfamily signaling in embryonic development and homeostasis. Dev Cell (2009) 16:329-43. doi:10.1016/j.devcel.2009.02.012.
39. Massagué J, Xi Q. TGF-β control of stem cell differentiation genes. FEBS Lett (2012) 586:1953-8. doi:10.1016/j.febslet.2012.03.023.
40. Xie F, Zhang Z, van Dam H, Zhang L, Zhou F. Regulation of TGF-β superfamily signaling by SMAD mono-ubiquitination. Cells (2014) 3:981-93. doi:10.3390/cells3040981.
41. Gordon J, Wilson VA, Blair NF, Sheridan J, Farley A, Wilson L, et al. Functional evidence for a single endodermal origin for the thymic epithelium. Nat Immunol (2004) 5:546-53. doi:10.1038/ni1064.
42. Gordon J, Manley NR. Mechanisms of thymus organogenesis and morphogenesis. Development (2011) 138:3865-78. doi:10.1242/dev.059998.
43. Sadler TW. Langman's Medical Embryology. 12th ed. Philadelphia, PA: Lippincott Williams & Wilkins (2012).
44. Farley AM, Morris LX, Vroegindeweij E, Depreter MLG, Vaidya H, Stenhouse FH, et al. Dynamics of thymus organogenesis and colonization in early human development. Development (2013) 140:2015-26. doi:10.1242/dev.087320.
45. Manley NR, Capecchi MR. Hox group 3 paralogs regulate the development and migration of the thymus, thyroid, and parathyroid glands. Dev Biol (1998) 195:1-15. doi:10.1006/dbio.1997.8827.
46. Hamazaki Y, Fujita H, Kobayashi T, Choi Y, Scott HS, Matsumoto M, et al. Medullary thymic epithelial cells expressing Aire represent a unique lineage derived from cells expressing claudin. Nat Immunol (2007) 8:304-11. doi:10.1038/ni1438.
47. Muñoz JJ, Cejalvo T, Tobajas E, Fanlo L, Cortés A, Zapata AG. 3D immunofluorescence analysis of early thymic morphogenesis and medulla development. Histol Histopathol (2015) 30:589-99. doi:10.14670/HH-30.589.
48. Van Ewijk W, Holländer G, Terhorst C, Wang B. Stepwise development of thymic microenvironments in vivo is regulated by thymocyte subsets. Development (2000) 127:1583-91.
49. Nehls M, Kyewski B, Messerle M, Waldschütz R, Schüddekopf K, Smith AJ, et al. Two genetically separable steps in the differentiation of thymic epithelium. Science (1996) 272:886-9. doi:10.1126/science.272.5263.886.
50. Günther T, Chen ZF, Kim J, Priemel M, Rueger JM, Amling M, et al. Genetic ablation of parathyroid glands reveals another source of parathyroid hormone. Nature (2000) 406:199-203. doi:10.1038/35018111.
51. Gordon J, Bennett AR, Blackburn CC, Manley NR. Gcm2 and Foxn1 mark early parathyroid-and thymus-specific domains in the developing third pharyngeal pouch. Mech Dev (2001) 103:141-3. doi:10.1016/S0925-4773(01)00333-1.
52. Liu Z, Farley A, Chen L, Kirby BJ, Kovacs CS, Blackburn CC, et al. Thymus-associated parathyroid hormone has two cellular origins with distinct endocrine and immunological functions. PLoS Genet (2010) 6:e1001251. doi:10.1371/journal.pgen.1001251.
53. Dooley J, Erickson M, Roelink H, Farr AG. Nude thymic rudiment lacking functional Foxn1 resembles respiratory epithelium. Dev Dyn (2005) 233:1605-12. doi:10.1002/dvdy.20495.
54. Haynes BF, Heinly CS. Early human T cell development: analysis of the human thymus at the time of initial entry of hematopoietic stem cells into the fetal thymic microenvironment. J Exp Med (1995) 181:1445-58. doi:10.1084/jem.181.4.1445.
55. Ramond C, Berthault C, Burlen-Defranoux O, de Sousa AP, Guy-Grand D, Vieira P, et al. Two waves of distinct hematopoietic progenitor cells colonize the fetal thymus. Nat Immunol (2014) 15:27-35. doi:10.1038/ni.2782.
56. Jiang X, Rowitch DH, Soriano P, McMahon AP, Sucov HM. Fate of the mammalian cardiac neural crest. Development (2000) 127:1607-16.
57. Patel SR, Gordon J, Mahbub F, Blackburn CC, Manley NR. Bmp4 and Noggin expression during early thymus and parathyroid organogenesis. Gene Expr Patterns (2006) 6:794-9. doi:10.1016/j.modgep.2006.01.011.
58. Gordon J, Patel SR, Mishina Y, Manley NR. Evidence for an early role for BMP4 signaling in thymus and parathyroid morphogenesis. Dev Biol (2010) 339:141-54. doi:10.1016/j.ydbio.2009.12.026.
59. Neves H, Dupin E, Parreira L, Le Douarin NM. Modulation of Bmp4 signalling in the epithelial-mesenchymal interactions that take place in early thymus and parathyroid development in avian embryos. Dev Biol (2012) 361:208-19. doi:10.1016/j.ydbio.2011.10.022.
60. Moore-Scott BA, Opoka R, Lin S-CJ, Kordich JJ, Wells JM. Identification of molecular markers that are expressed in discrete anterior-posterior domains of the endoderm from the gastrula stage to mid-gestation. Dev Dyn (2007) 236:1997-2003. doi:10.1002/dvdy.21204.
61. Sun X, Xu J, Lu H, Liu W, Miao Z, Sui X, et al. Directed differentiation of human embryonic stem cells into thymic epithelial progenitor-like cells reconstitutes the thymic microenvironment in vivo. Cell Stem Cell (2013) 13:230-6. doi:10.1016/j.stem.2013.06.014.
62. Conlon FL, Lyons KM, Takaesu N, Barth KS, Kispert A, Herrmann B, et al. A primary requirement for nodal in the formation and maintenance of the primitive streak in the mouse. Development (1994) 120:1919-28.
63. Zhang H, Bradley A. Mice deficient for BMP2 are nonviable and have defects in amnion/chorion and cardiac development. Development (1996) 122:2977-86.
64. Lawson KA, Dunn NR, Roelen BAJ, Zeinstra LM, Davis AM, Wright CVE, et al. Bmp4 is required for the generation of primordial germ cells in the mouse embryo. Genes Dev (1999) 13:424-36. doi:10.1101/gad.13.4.424.
65. Rossi SW, Jenkinson WE, Anderson G, Jenkinson EJ. Clonal analysis reveals a common progenitor for thymic cortical and medullary epithelium. Nature (2006) 441:988-91. doi:10.1038/nature04813.
66. Wong K, Lister NL, Barsanti M, Lim JMC, Hammett MV, Khong DM, et al. Multilineage potential and self-renewal define an epithelial progenitor cell population in the adult thymus. Cell Rep (2014) 8:1198-209. doi:10.1016/j.celrep.2014.07.029.
67. Danzl NM, Jeong S, Choi Y, Alexandropoulos K. Identification of novel thymic epithelial cell subsets whose differentiation is regulated by RANKL and Traf6. PLoS One (2014) 9:e86129. doi:10.1371/journal.pone.0086129.
68. Farr AG, Anderson SK. Epithelial heterogeneity in the murine thymus: fucose-specific lectins bind medullary epithelial cells. J Immunol (1985) 134:2971-7.
69. Klug DB, Carter C, Crouch E, Roop D, Conti CJ, Richie ER. Interdependence of cortical thymic epithelial cell differentiation and T-lineage commitment. Proc Natl Acad Sci U S A (1998) 95:11822-7. doi:10.1073/pnas.95.20.11822.
70. Murata S, Sasaki K, Kishimoto T, Niwa S, Hayashi H, Takahama Y, et al. Regulation of CD8+ T cell development by thymus-specific proteasomes. Science (2007) 316:1349-53. doi:10.1126/science.1141915.
71. St-Pierre C, Brochu S, Vanegas JR, Dumont-Lagacé M, Lemieux S, Perreault C. Transcriptome sequencing of neonatal thymic epithelial cells. Sci Rep (2013) 3:1860. doi:10.1038/srep01860.
72. Schluns KS, Grutkoski PS, Cook JE, Engelmann GL, Le PT. Human thymic epithelial cells produce TGF-beta 3 and express TGF-beta receptors. Int Immunol (1995) 7:1681-90. doi:10.1093/intimm/7.10.1681.
73. Anderson MS, Venanzi ES, Klein L, Chen Z, Berzins SP, Turley SJ, et al. Projection of an immunological self shadow within the thymus by the aire protein. Science (2002) 298:1395-401. doi:10.1126/science.1075958.
74. Anderson MS, Venanzi ES, Chen Z, Berzins SP, Benoist C, Mathis D. The cellular mechanism of Aire control of T cell tolerance. Immunity (2005) 23:227-39. doi:10.1016/j.immuni.2005.07.005.
75. Derbinski J, Gäbler J, Brors B, Tierling S, Jonnakuty S, Hergenhahn M, et al. Promiscuous gene expression in thymic epithelial cells is regulated at multiple levels. J Exp Med (2005) 202:33-45. doi:10.1084/jem.20050471.
76. Ohigashi I, Zuklys S, Sakata M, Mayer CE, Zhanybekova S, Murata S, et al. Aire-expressing thymic medullary epithelial cells originate from β5t-expressing progenitor cells. Proc Natl Acad Sci U S A (2013) 110:9885-90. doi:10.1073/pnas.1301799110.
77. Derbinski J, Schulte A, Kyewski B, Klein L. Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self. Nat Immunol (2001) 2:1032-9. doi:10.1038/ni723.
78. Melichar HJ, Ross JO, Herzmark P, Hogquist KA, Robey EA. Distinct temporal patterns of T cell receptor signaling during positive versus negative selection in situ. Sci Signal (2013) 6:ra92. doi:10.1126/scisignal.2004400.
79. Dzhagalov IL, Chen KG, Herzmark P, Robey EA. Elimination of self-reactive T cells in the thymus: a timeline for negative selection. PLoS Biol (2013) 11:e1001566. doi:10.1371/journal.pbio.1001566.
80. Konkel JE, Jin W, Abbatiello B, Grainger JR, Chen W. Thymocyte apoptosis drives the intrathymic generation of regulatory T cells. Proc Natl Acad Sci U S A (2014) 111:E465-73. doi:10.1073/pnas.1320319111.
81. Cejalvo T, Sacedón R, Hernández-López C, Diez B, Gutierrez-Frías C, Valencia J, et al. Bone morphogenetic protein-2/4 signalling pathway components are expressed in the human thymus and inhibit early T-cell development. Immunology (2007) 121:94-104. doi:10.1111/j.1365-2567.2007.02541.x.
82. Passa O, Tsalavos S, Belyaev NN, Petryk A, Potocnik AJ, Graf D. Compartmentalization of bone morphogenetic proteins and their antagonists in lymphoid progenitors and supporting microenvironments and functional implications. Immunology (2011) 134:349-59. doi:10.1111/j.1365-2567.2011.03495.x.
83. Kersten C, Sivertsen EA, Hystad ME, Forfang L, Smeland EB, Myklebust JH. BMP-6 inhibits growth of mature human B cells; induction of Smad phosphorylation and upregulation of Id1. BMC Immunol (2005) 6:9. doi:10.1186/1471-2172-6-9.
84. Ouyang W, Beckett O, Ma Q, Li MO. Transforming growth factor-beta signaling curbs thymic negative selection promoting regulatory T cell development. Immunity (2010) 32:642-53. doi:10.1016/j.immuni.2010.04.012.
85. Hauri-Hohl M, Zuklys S, Holländer GA, Ziegler SF. A regulatory role for TGF-β signaling in the establishment and function of the thymic medulla. Nat Immunol (2014) 15:554-61. doi:10.1038/ni.2869.
86. Marrella V, Poliani PL, Notarangelo LD, Villa A. Rag defects and thymic stroma: lessons from animal models. Front Immunol (2014) 5:529. doi:10.3389/fimmu.2014.00259.
87. Nehls M, Pfeifer D, Schorpp M, Hedrich H, Boehm T. New member of the winged-helix protein family disrupted in mouse and rat nude mutations. Nature (1994) 372:103-7. doi:10.1038/372103a0.
88. Balciunaite G, Keller MP, Balciunaite E, Piali L, Zuklys S, Mathieu YD, et al. Wnt glycoproteins regulate the expression of FoxN1, the gene defective in nude mice. Nat Immunol (2002) 3:1102-8. doi:10.1038/ni850.
89. Tsai PT, Lee RA, Wu H. BMP4 acts upstream of FGF in modulating thymic stroma and regulating thymopoiesis. Blood (2003) 102:3947-53. doi:10.1182/blood-2003-05-1657.
90. Bleul CC, Boehm T. BMP signaling is required for normal thymus development. J Immunol (2005) 175:5213-21. doi:10.4049/jimmunol.175.8.5213.
91. Talaber G, Kvell K, Varecza Z, Boldizsar F, Parnell SM, Jenkinson EJ, et al. Wnt-4 protects thymic epithelial cells against dexamethasone-induced senescence. Rejuvenation Res (2011) 14:241-8. doi:10.1089/rej.2010.1110.
92. Liang C-C, You L-R, Yen JJ, Liao N-S, Yang-Yen H-F, Chen C-M. Thymic epithelial β-catenin is required for adult thymic homeostasis and function. Immunol Cell Biol (2013) 91:511-23. doi:10.1038/icb.2013.34.
93. Lai L, Jin J. Generation of thymic epithelial cell progenitors by mouse embryonic stem cells. Stem Cells (2009) 27:3012-20. doi:10.1002/stem.238.
94. D'Amour KA, Agulnick AD, Eliazer S, Kelly OG, Kroon E, Baetge EE. Efficient differentiation of human embryonic stem cells to definitive endoderm. Nat Biotechnol (2005) 23:1534-41. doi:10.1038/nbt1163.
95. Green MD, Chen A, Nostro M-C, d'Souza SL, Schaniel C, Lemischka IR, et al. Generation of anterior foregut endoderm from human embryonic and induced pluripotent stem cells. Nat Biotechnol (2011) 29:267-72. doi:10.1038/nbt.1788.
96. Parent AV, Russ HA, Khan IS, Laflam TN, Metzger TC, Anderson MS, et al. Generation of functional thymic epithelium from human embryonic stem cells that supports host T cell development. Cell Stem Cell (2013) 13:219-29. doi:10.1016/j.stem.2013.04.004.
97. Douagi I, Andre I, Ferraz JC, Cumano A. Characterization of T cell precursor activity in the murine fetal thymus: evidence for an input of T cell precursors between days 12 and 14 of gestation. Eur J Immunol (2000) 30:2201-10. doi:10.1002/1521-4141(2000)30:8 < 2201:AID-IMMU2201 > 3.0.CO;2-2.
98. Liu C, Ueno T, Kuse S, Saito F, Nitta T, Piali L, et al. The role of CCL21 in recruitment of T-precursor cells to fetal thymi. Blood (2005) 105:31-9. doi:10.1182/blood-2004-04-1369.
99. Liu C, Saito F, Liu Z, Lei Y, Uehara S, Love P, et al. Coordination between CCR7-and CCR9-mediated chemokine signals in prevascular fetal thymus colonization. Blood (2006) 108:2531-9. doi:10.1182/blood-2006-05-024190.
100. Calderón L, Boehm T. Three chemokine receptors cooperatively regulate homing of hematopoietic progenitors to the embryonic mouse thymus. Proc Natl Acad Sci U S A (2011) 108:7517-22. doi:10.1073/pnas.1016428108.
101. Bleul CC, Boehm T. Chemokines define distinct microenvironments in the developing thymus. Eur J Immunol (2000) 30:3371-9. doi:10.1002/1521-4141(2000012)30:12<3371:AID-IMMU3371>3.0.CO;2-L.
102. Zaballos A, Gutiérrez J, Varona R, Ardavín C, Márquez G. Cutting edge: identification of the orphan chemokine receptor GPR-9-6 as CCR9, the receptor for the chemokine TECK. J Immunol (1999) 162:5671-5.
103. Youn BS, Kim CH, Smith FO, Broxmeyer HE. TECK, an efficacious chemoattractant for human thymocytes, uses GPR-9-6/CCR9 as a specific receptor. Blood (1999) 94:2533-6.
104. Yoshida R, Nagira M, Kitaura M, Imagawa N, Imai T, Yoshie O. Secondary lymphoid-tissue chemokine is a functional ligand for the CC chemokine receptor CCR7. J Biol Chem (1998) 273:7118-22. doi:10.1074/jbc.273.12.7118.
105. Jenkinson WE, Rossi SW, Parnell SM, Agace WW, Takahama Y, Jenkinson EJ, et al. Chemokine receptor expression defines heterogeneity in the earliest thymic migrants. Eur J Immunol (2007) 37:2090-6. doi:10.1002/eji.200737212.
106. Hillyer P, Mordelet E, Flynn G, Male D. Chemokines, chemokine receptors and adhesion molecules on different human endothelia: discriminating the tissue-specific functions that affect leucocyte migration. Clin Exp Immunol (2003) 134:431-41. doi:10.1111/j.1365-2249.2003.02323.x.
107. Lambrecht S, Smith V, De Wilde K, Coudenys J, Decuman S, Deforce D, et al. Growth differentiation factor 15, a marker of lung involvement in systemic sclerosis, is involved in fibrosis development but is not indispensable for fibrosis development. Arthritis Rheumatol (2014) 66:418-27. doi:10.1002/art.38241.
108. Kempf T, Zarbock A, Widera C, Butz S, Stadtmann A, Rossaint J, et al. GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice. Nat Med (2011) 17:581-8. doi:10.1038/nm.2354.
109. Carrillo-García C, Prochnow S, Simeonova IK, Strelau J, Hölzl-Wenig G, Mandl C, et al. Growth/differentiation factor 15 promotes EGFR signalling, and regulates proliferation and migration in the hippocampus of neonatal and young adult mice. Development (2014) 141:773-83. doi:10.1242/dev.096131.
110. Zhao X, Huang Y, Huang Y, Lei P, Peng J, Wu S, et al. Transforming growth factor-beta1 upregulates the expression of CXC chemokine receptor 4 (CXCR4) in human breast cancer MCF-7 cells. Acta Pharmacol Sin (2010) 31:347-54. doi:10.1038/aps.2009.204.
111. Yu S, Crawford D, Tsuchihashi T, Behrens TW, Srivastava D. The chemokine receptor CXCR7 functions to regulate cardiac valve remodeling. Dev Dyn (2011) 240:384-93. doi:10.1002/dvdy.22549.
112. Park BY, Hong CS, Sohail FA, Saint-Jeannet JP. Developmental expression and regulation of the chemokine CXCL14 in Xenopus. Int J Dev Biol (2009) 53:535-40. doi:10.1387/ijdb.092855bp.
113. Sierra-Filardi E, Nieto C, Domínguez-Soto A, Barroso R, Sánchez-Mateos P, Puig-Kroger A, et al. CCL2 shapes macrophage polarization by GM-CSF and M-CSF: identification of CCL2/CCR2-dependent gene expression profile. J Immunol (2014) 192:3858-67. doi:10.4049/jimmunol.1302821.
114. Wang B, Biron C, She J, Higgins K, Sunshine MJ, Lacy E, et al. A block in both early T lymphocyte and natural killer cell development in transgenic mice with high-copy numbers of the human CD3E gene. Proc Natl Acad Sci U S A (1994) 91:9402-6. doi:10.1073/pnas.91.20.9402.
115. Holländer GA, Wang B, Nichogiannopoulou A, Platenburg PP, van Ewijk W, BurakoffSJ, et al. Developmental control point in induction of thymic cortex regulated by a subpopulation of prothymocytes. Nature (1995) 373:350-3. doi:10.1038/373350a0.
116. Jenkinson WE, Rossi SW, Jenkinson EJ, Anderson G. Development of functional thymic epithelial cells occurs independently of lymphostromal interactions. Mech Dev (2005) 122:1294-9. doi:10.1016/j.mod.2005.08.003.
117. Ohnemus S, Kanzler B, Jerome-Majewska LA, Papaioannou VE, Boehm T, Mallo M. Aortic arch and pharyngeal phenotype in the absence of BMP-dependent neural crest in the mouse. Mech Dev (2002) 119:127-35. doi:10.1016/S0925-4773(02)00345-3.
118. Liu Y, Jin Y, Li J, Seto E, Kuo E, Yu W, et al. Inactivation of Cdc42 in neural crest cells causes craniofacial and cardiovascular morphogenesis defects. Dev Biol (2013) 383:239-52. doi:10.1016/j.ydbio.2013.09.013.
119. Alt B, Elsalini OA, Schrumpf P, Haufs N, Lawson ND, Schwabe GC, et al. Arteries define the position of the thyroid gland during its developmental relocalisation. Development (2006) 133:3797-804. doi:10.1242/dev.02550.
120. Wang J, Nagy A, Larsson J, Dudas M, Sucov HM, Kaartinen V. Defective ALK5 signaling in the neural crest leads to increased postmigratory neural crest cell apoptosis and severe outflow tract defects. BMC Dev Biol (2006) 6:51. doi:10.1186/1471-213X-6-51.
121. Hauri-Hohl MM, Zuklys S, Keller MP, Jeker LT, Barthlott T, Moon AM, et al. TGF-beta signaling in thymic epithelial cells regulates thymic involution and postirradiation reconstitution. Blood (2008) 112:626-34. doi:10.1182/blood-2007-10-115618.
122. Foster K, Sheridan J, Veiga-Fernandes H, Roderick K, Pachnis V, Adams R, et al. Contribution of neural crest-derived cells in the embryonic and adult thymus. J Immunol (2008) 180:3183-9. doi:10.4049/jimmunol.180.5.3183.
123. Crivellato E, Vacca A, Ribatti D. Setting the stage: an anatomist's view of the immune system. Trends Immunol (2004) 25:210-7. doi:10.1016/j.it.2004.02.008.
124. Pearse G. Normal structure, function and histology of the thymus. Toxicol Pathol (2006) 34:504-14. doi:10.1080/01926230600865549.
125. Gameiro J, Nagib P, Verinaud L. The thymus microenvironment in regulating thymocyte differentiation. Cell Adh Migr (2010) 4:382-90. doi:10.4161/cam.4.3.11789.
126. Berrih S, Savino W, Cohen S. Extracellular matrix of the human thymus: immunofluorescence studies on frozen sections and cultured epithelial cells. J Histochem Cytochem (1985) 33:655-64. doi:10.1177/33.7.3891843.
127. Heng TSP, Painter MW. The Immunological Genome Project: networks of gene expression in immune cells. Nat Immunol (2008) 9:1091-4. doi:10.1038/ni1008-1091.
128. Hager-Theodorides AL, Outram SV, Shah DK, Sacedon R, Shrimpton RE, Vicente A, et al. Bone morphogenetic protein 2/4 signaling regulates early thymocyte differentiation. J Immunol (2002) 169:5496-504. doi:10.4049/jimmunol.169.10.5496.
129. Hager-Theodorides AL, Ross SE, Sahni H, Mishina Y, Furmanski AL, Crompton T. Direct BMP2/4 signaling through BMP receptor IA regulates fetal thymocyte progenitor homeostasis and differentiation to CD4 + CD8 + double-positive cell. Cell Cycle (2014) 13:324-33. doi:10.4161/cc.27118.
130. Licona P, Chimal-Monroy J, Soldevila G. Inhibins are the major activin ligands expressed during early thymocyte development. Dev Dyn (2006) 235:1124-32. doi:10.1002/dvdy.20707.
131. Mingueneau M, Kreslavsky T, Gray D, Heng T, Cruse R, Ericson J, et al. The transcriptional landscape of αβ T cell differentiation. Nat Immunol (2013) 14:619-32. doi:10.1038/ni.2590.
132. Loffredo FS, Steinhauser ML, Jay SM, Gannon J, Pancoast JR, Yalamanchi P, et al. Growth differentiation factor 11 is a circulating factor that reverses age-related cardiac hypertrophy. Cell (2013) 153:828-39. doi:10.1016/j.cell.2013.04.015.
133. Savino W. Intrathymic T cell migration is a multivectorial process under a complex neuroendocrine control. Neuroimmunomodulation (2010) 17:142-5. doi:10.1159/000258708.
134. Rosendahl A, Speletas M, Leandersson K, Ivars F, Sideras P. Transforming growth factor-beta-and Activin-Smad signaling pathways are activated at distinct maturation stages of the thymopoeisis. Int Immunol (2003) 15:1401-14. doi:10.1093/intimm/dxg139.
135. Yoshioka Y, Ono M, Osaki M, Konishi I, Sakaguchi S. Differential effects of inhibition of bone morphogenic protein (BMP) signalling on T-cell activation and differentiation. Eur J Immunol (2012) 42:749-59. doi:10.1002/eji.201141702.
136. Sanos SL, Nowak J, Fallet M, BajenoffM. Stromal cell networks regulate thymocyte migration and dendritic cell behavior in the thymus. J Immunol (2011) 186:2835-41. doi:10.4049/jimmunol.1003563.
137. Savino W, Mendes-Da-Cruz DA, Smaniotto S, Silva-Monteiro E, Villa-Verde DMS. Molecular mechanisms governing thymocyte migration: combined role of chemokines and extracellular matrix. J Leukoc Biol (2004) 75:951-61. doi:10.1189/jlb.1003455.
138. Von Boehmer H. Selection of the T-cell repertoire: receptor-controlled checkpoints in T-cell development. Adv Immunol (2004) 84:201-38. doi:10.1016/S0065-2776(04)84006-9.
139. Ferreira LMR. Gammadelta T cells: innately adaptive immune cells? Int Rev Immunol (2013) 32:223-48. doi:10.3109/08830185.2013.783831.
140. Luc S, Luis TC, Boukarabila H, Macaulay IC, Buza-Vidas N, Bouriez-Jones T, et al. The earliest thymic T cell progenitors sustain B cell and myeloid lineage potential. Nat Immunol (2012) 13:412-9. doi:10.1038/ni.2255.
141. Ciofani M, Zúñiga-Pflücker JC. The thymus as an inductive site for T lymphopoiesis. Annu Rev Cell Dev Biol (2007) 23:463-93. doi:10.1146/annurev.cellbio.23.090506.123547.
142. Schmitt TM, Ciofani M, Petrie HT, Zúñiga-Pflücker JC. Maintenance of T cell specification and differentiation requires recurrent notch receptor-ligand interactions. J Exp Med (2004) 200:469-79. doi:10.1084/jem.20040394.
143. Dudley EC, Petrie HT, Shah LM, Owen MJ, Hayday AC. T cell receptor beta chain gene rearrangement and selection during thymocyte development in adult mice. Immunity (1994) 1:83-93. doi:10.1016/1074-7613(94)90102-3.
144. Aleman-Muench GR, Mendoza V, Stenvers K, Garcia-Zepeda EA, Lopez-Casillas F, Raman C, et al. Betaglycan (TβRIII) is expressed in the thymus and regulates T cell development by protecting thymocytes from apoptosis. PLoS One (2012) 7:e44217. doi:10.1371/journal.pone.0044217.
145. López-Casillas F, Wrana JL, Massagué J. Betaglycan presents ligand to the TGF beta signaling receptor. Cell (1993) 73:1435-44. doi:10.1016/0092-8674(93)90368-Z.
146. López-Casillas F, Payne HM, Andres JL, Massagué J. Betaglycan can act as a dual modulator of TGF-β access to signaling receptors: mapping of ligand binding and GAG attachment sites. J Cell Biol (1994) 124:557-68. doi:10.1083/jcb.124.4.557.
147. Eickelberg O, Centrella M, Reiss M, Kashgarian M, Wells RG. Betaglycan inhibits TGF-β signaling by preventing type I-type II receptor complex formation: glycosaminoglycan modifications alter betaglycan function. J Biol Chem (2002) 277:823-9. doi:10.1074/jbc. M105110200.
148. Licona-Limón P, Alemán-Muench G, Chimal-Monroy J, Macías-Silva M, García-Zepeda EA, Matzuk MM, et al. Activins and inhibins: novel regulators of thymocyte development. Biochem Biophys Res Commun (2009) 381:229-35. doi:10.1016/j.bbrc.2009.02.029.
149. Plum J, De Smedt M, Leclercq G, Vandekerckhove B. Influence of TGF-beta on murine thymocyte development in fetal thymus organ culture. J Immunol (1995) 154:5789-98.
150. Graf D, Nethisinghe S, Palmer DB, Fisher AG, Merkenschlager M. The developmentally regulated expression of Twisted gastrulation reveals a role for bone morphogenetic proteins in the control of T cell development. J Exp Med (2002) 196:163-71. doi:10.1084/jem.20020276.
151. Suzuki N, Labosky PA, Furuta Y, Hargett L, Dunn R, Fogo AB, et al. Failure of ventral body wall closure in mouse embryos lacking a procollagen C-proteinase encoded by Bmp1, a mammalian gene related to Drosophila tolloid. Development (1996) 122:3587-95.
152. Surh CD, Sprent J. T-cell apoptosis detected in situ during positive and negative selection in the thymus. Nature (1994) 372:100-3. doi:10.1038/372100a0.
153. Yamasaki S, Ishikawa E, Sakuma M, Ogata K, Sakata-Sogawa K, Hiroshima M, et al. Mechanistic basis of pre-T cell receptor-mediated autonomous signaling critical for thymocyte development. Nat Immunol (2006) 7:67-75. doi:10.1038/ni1290.
154. Crompton T, Moore M, MacDonald HR, Malissen B. Double-negative thymocyte subsets in CD3ζ chain-deficient mice: absence of HSA+CD44-CD25-cells. Eur J Immunol (1994) 24:1903-7. doi:10.1002/eji.1830240828.
155. Petrie HT, Livak F, Schatz DG, Strasser A, Crispe IN, Shortman K. Multiple rearrangements in T cell receptor alpha chain genes maximize the production of useful thymocytes. J Exp Med (1993) 178:615-22. doi:10.1084/jem.178.2.615.
156. Morris GP, Allen PM. How the TCR balances sensitivity and specificity for the recognition of self and pathogens. Nat Immunol (2012) 13:121-8. doi:10.1038/ni.2190.
157. Oh SP, Yeo C-Y, Lee Y, Schrewe H, Whitman M, Li E. Activin type IIA and IIB receptors mediate Gdf11 signaling in axial vertebral patterning. Genes Dev (2002) 16:2749-54. doi:10.1101/gad.1021802.
158. Mazerbourg S, Sangkuhl K, Luo CW, Sudo S, Klein C, Hsueh AJW. Identification of receptors and signaling pathways for orphan bone morphogenetic protein/growth differentiation factor ligands based on genomic analyses. J Biol Chem (2005) 280:32122-32. doi:10.1074/jbc. M504629200.
159. Andersson O, Reissmann E, Ibáñez CF. Growth differentiation factor 11 signals through the transforming growth factor-beta receptor ALK5 to regionalize the anterior-posterior axis. EMBO Rep (2006) 7:831-7. doi:10.1038/sj.embor.7400752.
160. Lee KJ, Mendelsohn M, Jessell TM. Neuronal patterning by BMPs: a requirement for GDF7 in the generation of a discrete class of commissural interneurons in the mouse spinal cord. Genes Dev (1998) 12:3394-407. doi:10.1101/gad.12.21.3394.
161. Settle S, Marker P, Gurley K, Sinha A, Thacker A, Wang Y, et al. The BMP family member Gdf7 is required for seminal vesicle growth, branching morphogenesis, and cytodifferentiation. Dev Biol (2001) 234:138-50. doi:10.1006/dbio.2001.0244.
162. McPherron AC, Lawler AM, Lee SJ. Regulation of anterior/posterior patterning of the axial skeleton by growth/differentiation factor 11. Nat Genet (1999) 22:260-4. doi:10.1038/10320.
163. Jurberg AD, Aires R, Varela-Lasheras I, Nóvoa A, Mallo M. Switching axial progenitors from producing trunk to tail tissues in vertebrate embryos. Dev Cell (2013) 25:451-62. doi:10.1016/j.devcel.2013.05.009.
164. Esquela AF, Lee S-J. Regulation of metanephric kidney development by growth/differentiation factor 11. Dev Biol (2003) 257:356-70. doi:10.1016/S0012-1606(03)00100-3.
165. Li Y, Messina C, Bendaoud M, Fine DH, Schreiner H, Tsiagbe VK. Adaptive immune response in osteoclastic bone resorption induced by orally administered Aggregatibacter actinomycetemcomitans in a rat model of periodontal disease. Mol Oral Microbiol (2010) 25:275-92. doi:10.1111/j.2041-1014.2010.00576.x.
166. Singer A, Adoro S, Park J-H. Lineage fate and intense debate: myths, models and mechanisms of CD4-versus CD8-lineage choice. Nat Rev Immunol (2008) 8:788-801. doi:10.1038/nri2416.
167. Adoro S, McCaughtry T, Erman B, Alag A, Van Laethem F, Park J-H, et al. Coreceptor gene imprinting governs thymocyte lineage fate. EMBO J (2012) 31:366-77. doi:10.1038/emboj.2011.388.
168. Stenvers KL, Tursky ML, Harder KW, Kountouri N, Amatayakul-Chantler S, Grail D, et al. Heart and liver defects and reduced transforming growth factor beta2 sensitivity in transforming growth factor beta type III receptor-deficient embryos. Mol Cell Biol (2003) 23:4371-85. doi:10.1128/MCB.23.12.4371-4385.2003.
169. Gray PC, Shani G, Aung K, Kelber J, Vale W. Cripto binds transforming growth factor beta (TGF-beta) and inhibits TGF-beta signaling. Mol Cell Biol (2006) 26:9268-78. doi:10.1128/MCB.01168-06.
170. Ding J, Yang L, Yan YT, Chen A, Desai N, Wynshaw-Boris A, et al. Cripto is required for correct orientation of the anterior-posterior axis in the mouse embryo. Nature (1998) 395:702-7. doi:10.1038/27215.
171. Xu C, Liguori G, Persico MG, Adamson ED. Abrogation of the Cripto gene in mouse leads to failure of postgastrulation morphogenesis and lack of differentiation of cardiomyocytes. Development (1999) 126:483-94. doi:10.1006/dbio.1998.8862.
172. Ohkura N, Kitagawa Y, Sakaguchi S. Development and maintenance of regulatory T cells. Immunity (2013) 38:414-23. doi:10.1016/j.immuni.2013.03.002.
173. Lee HM, Bautista JL, Scott-Browne J, Mohan JF, Hsieh CSA. Broad range of self-reactivity drives thymic regulatory T cell selection to limit responses to self. Immunity (2012) 37:475-86. doi:10.1016/j.immuni.2012.07.009.
174. Klein L, Kyewski B, Allen PM, Hogquist KA. Positive and negative selection of the T cell repertoire: what thymocytes see (and don't see). Nat Rev Immunol (2014) 14:377-91. doi:10.1038/nri3667.
175. Zorn E, Nelson EA, Mohseni M, Porcheray F, Kim H, Litsa D, et al. IL-2 regulates FOXP3 expression in human CD4 + CD25 + regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo. Blood (2006) 108:1571-9. doi:10.1182/blood-2006-02-004747.
176. Zeiser R, Negrin RS. Interleukin-2 receptor downstream events in regulatory T cells: implications for the choice of immunosuppressive drug therapy. Cell Cycle (2008) 7:458-62. doi:10.4161/cc.7.4.5454.
177. Burchill MA, Yang J, Vang KB, Moon JJ, Chu HH, Lio C-WJ, et al. Linked T cell receptor and cytokine signaling govern the development of the regulatory T cell repertoire. Immunity (2008) 28:112-21. doi:10.1016/j.immuni.2007.11.022.
178. Brunkow ME, Jeffery EW, Hjerrild KA, Paeper B, Clark LB, Yasayko SA, et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet (2001) 27:68-73. doi:10.1038/83784.
179. Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4 + CD25 + regulatory T cells. Nat Immunol (2003) 4:330-6. doi:10.1038/ni904.
180. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science (2003) 299:1057-61. doi:10.1126/science.1079490.
181. Gavin MA, Rasmussen JP, Fontenot JD, Vasta V, Manganiello VC, Beavo JA, et al. Foxp3-dependent programme of regulatory T-cell differentiation. Nature (2007) 445:771-5. doi:10.1038/nature05543.
182. Tai X, Erman B, Alag A, Mu J, Kimura M, Katz G, et al. Foxp3 transcription factor is proapoptotic and lethal to developing regulatory T cells unless counterbalanced by cytokine survival signals. Immunity (2013) 38:1116-28. doi:10.1016/j.immuni.2013.02.022.
183. Liu Y, Zhang P, Li J, Kulkarni AB, Perruche S, Chen W. A critical function for TGF-beta signaling in the development of natural CD4 + CD25 + Foxp3 + regulatory T cells. Nat Immunol (2008) 9:632-40. doi:10.1038/ni.1607.
184. Tone Y, Furuuchi K, Kojima Y, Tykocinski ML, Greene MI, Tone M. Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer. Nat Immunol (2008) 9:194-202. doi:10.1038/ni1549.
185. Xu L, Kitani A, Stuelten C, McGrady G, Fuss I, Strober W. Positive and negative transcriptional regulation of the Foxp3 gene is mediated by access and binding of the Smad3 protein to enhancer I. Immunity (2010) 33:313-25. doi:10.1016/j.immuni.2010.09.001.
186. Josefowicz SZ, Niec RE, Kim HY, Treuting P, Chinen T, Zheng Y, et al. Extrathymically generated regulatory T cells control mucosal TH2 inflammation. Nature (2012) 482:395-9. doi:10.1038/nature10772.
187. Marie JC, Letterio JJ, Gavin M, Rudensky AY. TGF-beta1 maintains suppressor function and Foxp3 expression in CD4 + CD25 + regulatory T cells. J Exp Med (2005) 201:1061-7. doi:10.1084/jem.20042276.
188. Kaartinen V, Voncken JW, Shuler C, Warburton D, Bu D, Heisterkamp N, et al. Abnormal lung development and cleft palate in mice lacking TGF-beta 3 indicates defects of epithelial-mesenchymal interaction. Nat Genet (1995) 11:415-21. doi:10.1038/ng1295-415.
189. Sanford LP, Ormsby I, Gittenberger-de Groot AC, Sariola H, Friedman R, Boivin GP, et al. TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes. Development (1997) 124:2659-70.
190. Proetzel G, Pawlowski SA, Wiles MV, Yin M, Boivin GP, Howles PN, et al. Transforming growth factor-beta 3 is required for secondary palate fusion. Nat Genet (1995) 11:409-14. doi:10.1038/ng1295-409.
191. Dünker N, Krieglstein K. Tgfβ2-/-Tgfβ3-/-double knockout mice display severe midline fusion defects and early embryonic lethality. Anat Embryol (Berl) (2002) 206:73-83. doi:10.1007/s00429-002-0273-6.
192. Mu Z, Yang Z, Yu D, Zhao Z, Munger JS. TGFβ1 and TGFβ3 are partially redundant effectors in brain vascular morphogenesis. Mech Dev (2008) 125:508-16. doi:10.1016/j.mod.2008.01.003.
193. McPherron AC, Huynh TV, Lee S-J. Redundancy of myostatin and growth/differentiation factor 11 function. BMC Dev Biol (2009) 9:24. doi:10.1186/1471-213X-9-24.
194. Do J, Fink PJ, Li L, Spolski R, Robinson J, Leonard WJ, et al. Cutting edge: spontaneous development of IL-17-producing gamma delta T cells in the thymus occurs via a TGF-beta 1-dependent mechanism. J Immunol (2010) 184:1675-9. doi:10.4049/jimmunol.0903539.
195. Michel M-L, Mendes-da-Cruz D, Keller AC, Lochner M, Schneider E, Dy M, et al. Critical role of ROR-γt in a new thymic pathway leading to IL-17-producing invariant NKT cell differentiation. Proc Natl Acad Sci U S A (2008) 105:19845-50. doi:10.1073/pnas.0806472105.
196. Lee YJ, Holzapfel KL, Zhu J, Jameson SC, Hogquist KA. Steady-state production of IL-4 modulates immunity in mouse strains and is determined by lineage diversity of iNKT cells. Nat Immunol (2013) 14:1146-54. doi:10.1038/ni.2731.
197. Monteiro M, Almeida CF, Agua-Doce A, Graca L. Induced IL-17-producing invariant NKT cells require activation in presence of TGF-β and IL-1β. J Immunol (2013) 190:805-11. doi:10.4049/jimmunol.1201010.
198. Havenar-Daughton C, Li S, Benlagha K, Marie JC. Development and function of murine ROR t+ iNKT cells are under TGF-signaling control. Blood (2012) 119:3486-94. doi:10.1182/blood-2012-01-401604.
199. Rando TA, Chang HY. Aging, rejuvenation, and epigenetic reprogramming: resetting the aging clock. Cell (2012) 148:46-57. doi:10.1016/j.cell.2012.01.003.
200. Douek DC, McFarland RD, Keiser PH, Gage EA, Massey JM, Haynes BF, et al. Changes in thymic function with age and during the treatment of HIV infection. Nature (1998) 396:690-5. doi:10.1038/25374.
201. Coelho VDM, Bunbury A, Rangel LB, Giri B, Weeraratna A, Morin PJ, et al. Fat-storing multilocular cells expressing CCR5 increase in the thymus with advancing age: potential role for CCR5 ligands on the differentiation and migration of preadipocytes. Int J Med Sci (2010) 7:1-14. doi:10.7150/ijms.7.1.
202. Müller L, Pawelec G. Aging and immunity-impact of behavioral intervention. Brain Behav Immun (2014) 39:8-22. doi:10.1016/j.bbi.2013.11.015.
203. Ventevogel MS, Sempowski GD. Thymic rejuvenation and aging. Curr Opin Immunol (2013) 25:516-22. doi:10.1016/j.coi.2013.06.002.
204. Sutherland JS, Goldberg GL, Hammett MV, Uldrich AP, Berzins SP, Heng TS, et al. Activation of thymic regeneration in mice and humans following androgen blockade. J Immunol (2005) 175:2741-53. doi:10.4049/jimmunol.175.4.2741.
205. Hirakata A, Okumi M, Griesemer AD, Shimizu A, Nobori S, Tena A, et al. Reversal of age-related thymic involution by an LHRH agonist in miniature swine. Transpl Immunol (2010) 24:76-81. doi:10.1016/j.trim.2010.08.001.
206. Berent-Maoz B, Montecino-Rodriguez E, Signer RAJ, Dorshkind K. Fibroblast growth factor-7 partially reverses murine thymocyte progenitor aging by repression of Ink4a. Blood (2012) 119:5715-21. doi:10.1182/blood-2011-12-400002.
207. Min D, Panoskaltsis-Mortari A, Kuro-o M, Holländer GA, Blazar BR, Weinberg KI. Sustained thymopoiesis and improvement in functional immunity induced by exogenous KGF administration in murine models of aging. Blood (2007) 109:2529-37. doi:10.1182/blood-2006-08-043794.
208. Morrhaye G, Kermani H, Legros J-J, Baron F, Beguin Y, Moutschen M, et al. Impact of growth hormone (GH) deficiency and GH replacement upon thymus function in adult patients. PLoS One (2009) 4:e5668. doi:10.1371/journal.pone.0005668.
209. Taub DD, Murphy WJ, Longo DL. Rejuvenation of the aging thymus: growth hormone-mediated and ghrelin-mediated signaling pathways. Curr Opin Pharmacol (2010) 10:408-24. doi:10.1016/j.coph.2010.04.015.
210. Phillips JA, Brondstetter TI, English CA, Lee HE, Virts EL, Thoman ML. IL-7 gene therapy in aging restores early thymopoiesis without reversing involution. J Immunol (2004) 173:4867-74. doi:10.4049/jimmunol.173.8.4867.
211. Velardi E, Dudakov JA, Van den Brink MRM. Clinical strategies to enhance thymic recovery after allogeneic hematopoietic stem cell transplantation. Immunol Lett (2013) 155:31-5. doi:10.1016/j.imlet.2013.09.016.
212. Zook EC, Krishack PA, Zhang S, Zeleznik-Le NJ, Firulli AB, Witte PL, et al. Overexpression of Foxn1 attenuates age-associated thymic involution and prevents the expansion of peripheral CD4 memory T cells. Blood (2011) 118:5723-31. doi:10.1182/blood-2011-03-342097.
213. Bredenkamp N, Nowell CS, Blackburn CC. Regeneration of the aged thymus by a single transcription factor. Development (2014) 141:1627-37. doi:10.1242/dev.103614.
214. Bredenkamp N, Ulyanchenko S, O'Neill KE, Manley NR, Vaidya HJ, Blackburn CC. An organized and functional thymus generated from FOXN1-reprogrammed fibroblasts. Nat Cell Biol (2014) 16(9):902-8. doi:10.1038/ncb3023.
215. Sinha M, Jang YC, Oh J, Khong D, Wu EY, Manohar R, et al. Restoring systemic GDF11 levels reverses age-related dysfunction in mouse skeletal muscle. Science (2014) 344:649-52. doi:10.1126/science.1251152.
216. Katsimpardi L, Litterman NK, Schein PA, Miller CM, Loffredo FS, Wojtkiewicz GR, et al. Vascular and neurogenic rejuvenation of the aging mouse brain by young systemic factors. Science (2014) 344:630-4. doi:10.1126/science.1251141.
217. Zhang Y, Shao J, Wang Z, Yang T, Liu S, Liu Y, et al. Growth differentiation factor 11 is a protective factor for osteoblastogenesis by targeting PPARgamma. Gene (2014) 557(2):6-11. doi:10.1016/j.gene.2014.12.039.
218. Finkenzeller G, Stark GB, Strassburg S. Growth differentiation factor 11 supports migration and sprouting of endothelial progenitor cells. J Surg Res (2015) 198(1):1-7. doi:10.1016/j.jss.2015.05.001.
219. Suragani RNVS, Cadena SM, Cawley SM, Sako D, Mitchell D, Li R, et al. Transforming growth factor-β superfamily ligand trap ACE-536 corrects anemia by promoting late-stage erythropoiesis. Nat Med (2014) 20:408-14. doi:10.1038/nm.3512.
220. Egerman MA, Cadena SM, Gilbert JA, Meyer A, Nelson HN, Swalley SE, et al. GDF11 increases with age and inhibits skeletal muscle regeneration. Cell Metab (2015) 22(1):1-11. doi:10.1016/j.cmet.2015.05.010.
221. Pishel I, Shytikov D, Orlova T, Peregudov A, Artyuhov I, Butenko G. Accelerated aging versus rejuvenation of the immune system in heterochronic parabiosis. Rejuvenation Res (2012) 15:239-48. doi:10.1089/rej.2012.1331.